July 15, 2020: Oncology Home Infusion in Post-COVID-19 World: COVID-19 Recovery, the Road Ahead

Featuring:

Roger Brito, DO
Division Head
Enterprise Oncology
CVS Health/Aetna
Lisa Kennedy Sheldon, PhD, ANP-BC, AOCNP, FAAN
Scientific and Clinical Affairs Liaison
Oncology Nursing Society
Michael Kolodziej, MD
National Medical Director
Managed Care Strategy
Flatiron Health
New York, NY
Barbara L. McAneny, MD
Chief Executive Officer
New Mexico Oncology Hematology Consultants, Ltd
Albuquerque, NM
Steven Peskin, MD, MBA, FACP
Executive Medical Director of Population Health and Transformation, Horizon BCBS
Chevon Rariy, MD
Vice President & Chair, Virtual Health, Cancer Treatment Centers of America
Chicago, IL
Burt Zweigenhaft, PhD, D.Litt
Editor-in-Chief, VBCC;
Executive Vice President, FFF Enterprises;
Executive Director and Co-Founder, Association for Value-Based Cancer Care
The COVID-19 pandemic has led to the elimination of several restrictions on telehealth and infusion therapy in the home setting. In this webcast, a panel of experts discuss the short- and long-term prospects for in-home infusion for patients with cancer. What are the benefits and drawbacks?

Related Articles